Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients
Conclusion: The results of the current study suggest that patients whose PD-1 therapy has been discontinued in response can have a long IO therapy-free period without need for a next line of therapy.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Clinical Trials | Melanoma | Skin Cancer | Study